Rock Springs Capital Management LP Design Therapeutics, Inc. Transaction History

Rock Springs Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$9.91 - $17.33 $1.14 Million - $1.99 Million	114,794 Added 33.22%	460,391 $6.45 Million
Q1 2022 May 16, 2022	BUY	$11.17 - $20.89 $115,609 - $216,211	10,350 Added 3.09%	345,597 $5.58 Million
Q4 2021 Feb 14, 2022	BUY	$13.64 - $21.41 $16,327 - $25,627	1,197 Added 0.36%	335,247 $7.18 Million
Q3 2021 Nov 15, 2021	BUY	$13.99 - $20.03 $27,980 - $40,060	2,000 Added 0.6%	334,050 $4.91 Million
Q2 2021 Aug 16, 2021	BUY	$19.02 - $29.78 $91,296 - $142,944	4,800 Added 1.47%	332,050 $6.6 Million
Q1 2021 May 17, 2021	BUY	$29.52 - $41.49 $9.66 Million - $13.6 Million	327,250 New	327,250 $9.79 Million

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $252M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.